Targeted therapy in non-small cell lung cancer: myth or reality
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 41, 3-8
- https://doi.org/10.1016/s0169-5002(03)00133-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- What went wrong with Iressa?The Lancet Oncology, 2002
- The Simpleton’s Error in Drug DevelopmentJournal of Clinical Oncology, 2002
- Comprehensive analysis of promoter methylation and altered expression of hMLH1 in gastric cancer cell lines with microsatellite instabilityZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Lung Cancer — Time to Move on from ChemotherapyNew England Journal of Medicine, 2002
- Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group TrialJournal of Clinical Oncology, 2001
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine, 2001
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine, 2001
- Evolution of Cisplatin-Based Chemotherapy in Non-Small Cell Lung CancerChest, 2000
- Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtypeEuropean Journal Of Cancer, 1995